Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Neurobiology

• Publication date

  2015-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12035-015-9384-yPMID 26298663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats

  2016cited by this paper
• Neuroprotective effect of N-acetyl cysteine against streptozotocin-induced memory dysfunction and oxidative damage in rats

  2015cited by this paper
• Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia.

  2014cited by this paper
• Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin‐induced diabetic rats

  2014cited by this paper
• Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin.

  2014cited by this paper
• Effects of treadmill exercise on brain insulin signaling and β-amyloid in intracerebroventricular streptozotocin induced-memory impairment in rats

  2014cited by this paper
• Effect of Licofelone—A Dual COX/5-LOX Inhibitor in Intracerebroventricular Streptozotocin-Induced Behavioral and Biochemical Abnormalities in Rats

  2014cited by this paper
• Testosterone ameliorates streptozotocin-induced memory impairment in male rats

  2014cited by this paper
• Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences

  2014cited by this paper
• Postsynaptic distribution of IRSp53 in spiny excitatory and inhibitory neurons

  2014cited by this paper
• Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats.

  2014cited by this paper
• Efficacy of some antioxidants supplementation in reducing oxidative stress post sodium tungstate exposure in male wistar rats.

  2014cited by this paper
• Agmatine Improves Cognitive Dysfunction and Prevents Cell Death in a Streptozotocin-Induced Alzheimer Rat Model

  2014cited by this paper
• Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats.

  2013cited by this paper
• Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice

  2013cited by this paper
• Defensive Effect of Lansoprazole in Dementia of AD Type in Mice Exposed to Streptozotocin and Cholesterol Enriched Diet

  2013cited by this paper
• Neuroprotective effects of Pouteria ramiflora (Mart.) Radlk (Sapotaceae) extract on the brains of rats with streptozotocin-induced diabetes

  2013cited by this paper
• Clitoria ternatea ameliorated the intracerebroventricularly injected streptozotocin induced cognitive impairment in rats: behavioral and biochemical evidence

  2013influential reference
• Insulin/IGF Signaling-Related Gene Expression in the Brain of a Sporadic Alzheimer's Disease Monkey Model Induced by Intracerebroventricular Injection of Streptozotocin

  2013cited by this paper
• Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer’s disease type: possible involvement of PPAR-γ agonistic property

  2013cited by this paper
• Protective effects of oral crocin against intracerebroventricular streptozotocin-induced spatial memory deficit and oxidative stress in rats.

  2013cited by this paper
• A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats.

  2013cited by this paper
• Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats.

  2013cited by this paper
• Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia.

  2013cited by this paper
• Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer’s type (SDAT) caused by intracerebroventricular streptozotocin in rats

  2013cited by this paper
• Neuroprotective effects of donepezil against cholinergic depletion

  2013cited by this paper
• Ameliorative effect of Noni fruit extract on streptozotocin-induced memory impairment in mice

  2013cited by this paper
• Nesfatin-1 Stimulates Fatty-Acid Oxidation by Activating AMP-Activated Protein Kinase in STZ-Induced Type 2 Diabetic Mice

  2013cited by this paper
• Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes.

  2013cited by this paper
• Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus.

  2012cited by this paper
• The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease

  2012cited by this paper
• A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats.

  2012cited by this paper
• Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats.

  2012cited by this paper
• Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice

  2012cited by this paper
• Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment

  2012cited by this paper
• Amyloid-β Protein Modulates Insulin Signaling in Presynaptic Terminals

  2012cited by this paper
• Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

  2012cited by this paper
• Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents.

  2012cited by this paper
• Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type.

  2012cited by this paper
• Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism.

  2012cited by this paper
• Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model.

  2012cited by this paper
• Amelioration of intracerebroventricular streptozotocin induced cognitive impairment by Evolvulus alsinoides in rats: in vitro and in vivo evidence.

  2012cited by this paper
• Stress-Induced Cytokines and Neuronal Dysfunction in Alzheimer's Disease

  2012cited by this paper
• Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1–7) mas receptor expression associated with its PPAR-γ agonist action

  2011cited by this paper
• ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor.

  2011cited by this paper
• Neuroprotective Effect of Cyclooxygenase Inhibitors in ICV-STZ Induced Sporadic Alzheimer’s Disease in Rats

  2011cited by this paper
• Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.

  2011cited by this paper
• Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain.

  2011cited by this paper
• Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model.

  2011cited by this paper
• Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies.

  2011cited by this paper
• A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease.

  2011cited by this paper
• S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type.

  2011cited by this paper
• P3‐184: Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin‐administered rats

  2011cited by this paper
• Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling

  2011cited by this paper
• A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.

  2011cited by this paper
• Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study

  2011cited by this paper
• Melatonin alleviates memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats.

  2010cited by this paper
• Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin

  2010cited by this paper
• Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Exacerbates Alzheimer-like Changes in Tg2576 AβPP-Overexpressing Mice

  2010cited by this paper
• Oxidative stress in Alzheimer disease: a possibility for prevention.

  2010cited by this paper
• Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia

  2010cited by this paper
• Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia.

  2010cited by this paper
• Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice.

  2010cited by this paper
• Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease.

  2010cited by this paper
• Neuroinflammation and Cognitive Aging

  2010cited by this paper
• Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow.

  2010cited by this paper
• Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat.

  2010cited by this paper
• Effects of active constituents of Crocus sativus L., crocin on streptozocin-induced model of sporadic Alzheimer's disease in male rats.

  2010cited by this paper
• Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats.

  2009cited by this paper
• Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.

  2009cited by this paper
• Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT).

  2009cited by this paper
• Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease

  2009cited by this paper
• Ginkgo biloba for cognitive impairment and dementia.

  2009cited by this paper
• Mitochondria, Cognitive Impairment, and Alzheimer's Disease

  2009cited by this paper
• Cytoskeletal pathologies of Alzheimer disease.

  2009cited by this paper
• A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia.

  2009cited by this paper
• AβPP A713T Mutation in Late Onset Alzheimer's Disease with Cerebrovascular Lesions

  2009cited by this paper
• Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.

  2009cited by this paper
• β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin

  2009cited by this paper
• Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

  2009cited by this paper
• Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.

  2009cited by this paper
• Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin.

  2009cited by this paper
• Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.

  2008cited by this paper
• Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.

  2008cited by this paper
• Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system.

  2008cited by this paper
• Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.

  2008cited by this paper
• Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil

  2008cited by this paper
• Effects of treadmill exercise on memory and c-Fos expression in the hippocampus of the rats with intracerebroventricular injection of streptozotocin.

  2008cited by this paper
• Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia.

  2008cited by this paper
• Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity

  2008cited by this paper
• Therapeutic potential of resveratrol in Alzheimer's disease

  2008cited by this paper
• Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease

  2008cited by this paper
• Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

  2007cited by this paper
• Neurodegenerative Diseases: Neurotoxins as Sufficient Etiologic Agents?

  2007cited by this paper
• Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

  2007cited by this paper
• LTP inhibits LTD in the hippocampus via regulation of GSK3beta.

  2007cited by this paper
• Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro.

  2007cited by this paper
• Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.

  2007cited by this paper

• Neuroprotective effects of plasma-activated N-acetylcysteine against streptozotocin-induced behavioral deficits in rats: Attenuation of oxidative stress and cholinergic dysfunction.

  2026cites this paper
• Xmu-mp-1 attenuates streptozotocin-induced neurotoxicity in SH-SY5Y cells: potential role of Hippo pathway modulation

  2026cites this paper
• Semaglutide slows the progression of cognitive impairment and pathological changes in the hippocampus in a model of Alzheimer's disease

  2025cites this paper
• The Role of TRPV1 in Type 1 Diabetes

  2025cites this paper
• Intracranial self-stimulation mitigates spatial task deficits, modifies miR-146a and miR-495 serum levels and restores hippocampal NRF2 levels in a rat model of sporadic Alzheimer’s disease

  2025cites this paper
• Neuromodulatory efficacy of Bacopa monniera extract against streptozotocin-induced neuronal dysfunction in SH-SY5Y cells: Implications for diabetic neuropathy.

  2025cites this paper
• Efficacy of Piper Longum Extract in a Streptozotocin-Induced Mouse Model of Sporadic Alzheimer’s Disease Combined with Chronic Restraint Through Lipocalin-2-Associated Neuroinflammatory Mechanism

  2025cites this paper
• Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer’s Disease Are Associated with the Peripheral Suppression of Inflammation

  2025cites this paper
• Experimental validation, molecular docking, proteomic analysis and network pharmacology reveal Morroniside promoting neurogenesis and improving cognitive impairment via Notch1/Hes1 pathway in intracerebroventricular-streptozotocin mice.

  2025cites this paper
• Vanadyl sulfate restores memory impairment in streptozotocin-induced rat model of sporadic alzheimer’s disease by repressing FoxO1 gene expression

  2025cites this paper
• Resveratrol Restores Insulin Signaling and Balances Mitochondrial Biogenesis and Autophagy in Streptozotocin-Induced Neurodegeneration in vitro.

  2025cites this paper
• Approaching therapy of Alzheimer’s disease via the antidiabetic drug liraglutide—a study with streptozotocin intracerebroventricularly treated Wistar rats

  2025cites this paper
• Sex-Associated Cerebellar and Hippocampal Volume Reduction in Alzheimer’s Disease: Insights from the Clinical ADNI Cohort and STZ Animal Model

  2025cites this paper
• Methionine Aminopeptidase 2 (MetAP2) Inhibitor BL6 Attenuates Inflammation in Cultured Microglia and in a Mouse Model of Alzheimer’s Disease

  2025cites this paper
• Investigating the neuroprotective effects of Dracocephalum moldavica extract and its effect on metabolomic profile of rat model of sporadic Alzheimer's disease

  2025cites this paper
• Selection of five different types of animal models of Alzheimer’s disease: based on pathological similarity and research objectives

  2025cites this paper
• Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology and amyloidogenesis.

  2024cites this paper
• Astrocyte dysfunction alters GABAergic communication and ammonia metabolism in the streptozotocin-induced sporadic Alzheimer's disease model

  2024cites this paper
• Exploring the Neuroprotective Effects of Rufinamide in a Streptozotocin-Induced Dementia Model

  2024cites this paper
• Biochemical investigation and in silico analysis of the therapeutic efficacy of Ipriflavone through Tet-1 Surface-Modified-PLGA nanoparticles in Streptozotocin-Induced Alzheimer's like Disease: Reduced oxidative damage and etiological Descriptors.

  2024cites this paper
• Stem cell therapy in Alzheimer’s disease: current status and perspectives

  2024cites this paper
• Aqueous extract of Spirulina exerts neuroprotection in an experimental model of Alzheimer sporadic disease in mice induced by Streptozotocin

  2024cites this paper
• Intermittent hypoxia-hyperoxia training ameliorates cognitive impairment and neuroinflammation in a rat model of Alzheimer's disease.

  2024cites this paper
• Effect of mesenchymal stem cells and polyvinyl alcohol-coated selenium nanoparticles on rats with Alzheimer-like phenotypes

  2024cites this paper
• Intranasal administration of insulin to rats with forebrain ischemia and reperfusion decreases the intensity of autophagy and apoptosis in hippocampus and frontal brain cortex, possible mechanism of unsulin action

  2024cites this paper
• Melatonin improves cognitive dysfunction and decreases gliosis in the streptozotocin-induced rat model of sporadic Alzheimer’s disease

  2024cites this paper
• Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer’s Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating Neuroinflammation

  2024cites this paper
• The Autophagic and Apoptotic Death of Forebrain Neurons of Rats with Global Brain Ischemia Is Diminished by the Intranasal Administration of Insulin: Possible Mechanism of Its Action

  2024cites this paper
• Ellagic Acid Reverses Alterations in the Expression of AMPA Receptor and Its Scaffolding Proteins in the Cerebral Cortex and Memory Decline in STZ-sporadic Alzheimer’ s Disease Mouse Model

  2024cites this paper
• MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer’s Disease by modulating Hippo-Wnt signaling crosstalk

  2024cites this paper
• Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia

  2024cites this paper
• Plasma Leptin and Alzheimer Protein Pathologies Among Older Adults

  2024cites this paper
• Intranasal Insulin Administration to Rats with Forebrain Ischemia and Reperfusion Injury Reduces Autophagy and Apoptosis Intensity in the Hippocampus and Frontal Cortex, a Possible Mechanism of Action

  2024cites this paper
• Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer’s pathology

  2024influential citation
• A Low-Molecular-Weight BDNF Mimetic, Dipeptide GSB-214, Prevents Memory Impairment in Rat Models of Alzheimer’s Disease

  2023cites this paper
• The effect of intra-nasal co-treatment with insulin and growth factor-rich serum on behavioral defects, hippocampal oxidative-nitrosative stress, and histological changes induced by icv-STZ in a rat model

  2023cites this paper
• Alzheimer's disease‐related brain insulin resistance and the prospective therapeutic impact of metformin

  2023cites this paper
• Neuroprotection elicited by taurine in sporadic Alzheimer-like disease: benefits on memory and control of neuroinflammation in the hippocampus of rats

  2023cites this paper
• Physiological Mechanisms Inherent to Diabetes Involved in the Development of Dementia: Alzheimer’s Disease

  2023cites this paper
• Montelukast Ameliorates Scopolamine-induced Alzheimer's Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF.

  2023cites this paper
• Memory impairment was ameliorated by corticolimbic microinjections of arachidonylcyclopropylamide (ACPA) and miRNA-regulated lentiviral particles in a streptozotocin-induced Alzheimer's rat model.

  2023cites this paper
• Protective effect of Allium jesdianum in an Alzheimer's disease induced rat model

  2023cites this paper
• Protective effect of a standardized Allium jesdianum extract in an Alzheimer's disease induced rat model.

  2023cites this paper
• State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease

  2023cites this paper
• Animal models of Alzheimer’s disease: preclinical insights and challenges

  2023cites this paper
• Pre- and post-treatment of α-Tocopherol on cognitive, synaptic plasticity, and mitochondrial disorders of the hippocampus in icv-streptozotocin-induced sporadic Alzheimer’s-like disease in male Wistar rat

  2023cites this paper
• In Vitro and in Vivo Evaluation of Multi-Target-Directed Rivastigmine/Memantine/Gingko Biloba-Loaded Nanofibers Against Alzheimer's Disease

  2023cites this paper
• Monitoring Alzheimer’s disease via ultraweak photon emission

  2023cites this paper
• Melatonin reduces β-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer’s disease model

  2023cites this paper
• Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance

  2023cites this paper
• Neuroprotective Efficacy of Europinidin in Streptozotocin-Induced Memory Impairment by Modulation of Oxidative Stress, Inflammatory Mediators, and Cholinesterase Activity in Rats

  2023cites this paper
• Effect of Letrozole on hippocampal Let-7 microRNAs and their correlation with working memory and phosphorylated Tau protein in an Alzheimer's disease-like rat model

  2022cites this paper
• Dimethyl Fumarate as the Peripheral Blood Inflammatory Mediators Inhibitor in Prevention of Streptozotocin-Induced Neuroinflammation in Aged Rats

  2022cites this paper
• Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia

  2022cites this paper
• Conductor of the Astrocyte-Neuron Metabolic Orchestra

  2022cites this paper
• Cognitive Dysfunction and Anxiety Resulting from Synaptic Downscaling, Hippocampal Atrophy, and Ventricular Enlargement with Intracerebroventricular Streptozotocin Injection in Male Wistar Rats

  2022cites this paper
• α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease.

  2022cites this paper
• Intermittent theta burst stimulation ameliorates cognitive impairment and hippocampal gliosis in the Streptozotocin-induced model of Alzheimer's disease.

  2022cites this paper
• Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation.

  2022cites this paper
• AMELIORATIVE EFFECT OF SESAME OIL ON STREPTOZOTOCON- INDUCED OXIDATIVE STRESS IN MALE RAT HIPPOCAMPUS

  2022cites this paper
• Andrographolide Attenuates Short-Term Spatial and Recognition Memory Impairment and Neuroinflammation Induced by a Streptozotocin Rat Model of Alzheimer’s Disease

  2022cites this paper
• Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats.

  2022cites this paper
• A Pathophysiological Intersection of Diabetes and Alzheimer’s Disease

  2022cites this paper
• The effects of polyvinyl alcohol-coated selenium nanoparticles on memory impairment in rats

  2022cites this paper
• Single and repeated bisphenol A treatment induces ROS, Aβ and hyperphosphorylated-tau accumulation, and insulin pathways disruption, through HDAC2 and PTP1B overexpression, leading to SN56 cholinergic apoptotic cell death.

  2022cites this paper
• XperCT-guided Intra-cisterna Magna Injection of Streptozotocin for Establishing an Alzheimer’s Disease Model Using the Cynomolgus Monkey (Macaca fascicularis)

  2022cites this paper
• Cognitive dysfunction and anxiety resulted from synaptic downscaling, hippocampal atrophy and ventricular enlargement in i.c.v. streptozotocin injected male Wistar rats

  2022cites this paper
• Role of Oxygen Radicals in Alzheimer’s Disease: Focus on Tau Protein

  2021cites this paper
• Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model

  2021cites this paper
• Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury.

  2021cites this paper
• Quercetin Exhibits α7nAChR/Nrf2/HO-1-Mediated Neuroprotection Against STZ-Induced Mitochondrial Toxicity and Cognitive Impairments in Experimental Rodents

  2021cites this paper
• Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways.

  2021cites this paper
• Effect of Letrozole on hippocampal let-7 microRNAs and their correlation with working memory and phosphorylated Tau protein level in an Alzheimer's disease rat model

  2021cites this paper
• Failure of the Brain Glucagon-Like Peptide-1-Mediated Control of Intestinal Redox Homeostasis in a Rat Model of Sporadic Alzheimer’s Disease

  2021cites this paper
• Tadalafil modulates intracerebroventricular streptozotocin-induced cognition and memory impairment in the young and middle middle-aged rats

  2021cites this paper
• A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice

  2021cites this paper
• 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer’s disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance

  2021cites this paper
• Protective Effect of Biobran/MGN-3 against Sporadic Alzheimer's Disease Mouse Model: Possible Role of Oxidative Stress and Apoptotic Pathways

  2021cites this paper
• Inhibition of complex I-III activity of brain mitochondria after intracerebroventricular administration of streptozotocin in rats is possibly related to loss of body weight

  2020cites this paper
• Advance of sporadic Alzheimer's disease animal models

  2020cites this paper
• Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: “Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats” by Ghosh et al., Metab Brain Dis 20

  2020cites this paper
• The bile acid TUDCA improves glucose metabolism in streptozotocin-induced Alzheimer's disease mice model.

  2020cites this paper
• Sinapic Acid Alleviates Oxidative Stress and Neuro-Inflammatory Changes in Sporadic Model of Alzheimer’s Disease in Rats

  2020cites this paper
• Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review

  2020cites this paper
• Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: “Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats” by Ghosh et al., Metab Brain Dis 20

  2020cites this paper
• Selenium nanoparticles and metformin ameliorate streptozotocin-instigated brain oxidative-inflammatory stress and neurobehavioral alterations in rats

  2020cites this paper
• Acteoside‐improved streptozotocin‐induced learning and memory impairment by upregulating hippocampal insulin, glucose transport, and energy metabolism

  2020cites this paper
• Ruthenium red, mitochondrial calcium uniporter inhibitor, attenuates cognitive deficits in STZ-ICV challenged experimental animals.

  2020cites this paper
• Sex-specific metabolic alterations in the type 1 diabetic brain of mice revealed by an integrated method of metabolomics and mixed-model

  2020cites this paper
• Streptozotocin Induces Alzheimer’s Disease-Like Pathology in Hippocampal Neuronal Cells via CDK5/Drp1-Mediated Mitochondrial Fragmentation

  2020cites this paper
• Intracerebroventricular streptozotocin administration impairs mitochondrial calcium homeostasis and bioenergetics in memory-sensitive rat brain regions

  2020cites this paper
• Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats

  2020influential citation
• Antia, a Natural Antioxidant Product, Attenuates Cognitive Dysfunction in Streptozotocin-Induced Mouse Model of Sporadic Alzheimer's Disease by Targeting the Amyloidogenic, Inflammatory, Autophagy, and Oxidative Stress Pathways

  2020cites this paper
• Intracerebroventricular streptozotocin induces behavioral impairments and increases short‑term C3 gene expression in the hippocampus of Wistar rats.

  2020cites this paper
• Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice.

  2020cites this paper
• Xanthotoxin and umbelliferone attenuate cognitive dysfunction in a streptozotocin‐induced rat model of sporadic Alzheimer's disease: The role of JAK2/STAT3 and Nrf2/HO‐1 signalling pathway modulation

  2020cites this paper
• Quantitative magnetic susceptibility assessed by 7T magnetic resonance imaging in Alzheimer's disease caused by streptozotocin administration.

  2020cites this paper
• Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies

  2020cites this paper
• Effect of amyloid toxicity or chronic cerebral hypoperfusion on brain insulin resistance in a rat model with intracerebroventricular streptozotocin.

  2020cites this paper
• Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer's disease

  2020cites this paper